NewEdge Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
19,253
+258
| +1% | +$22.5K | 0.01% | 1021 |
|
|
2025
Q1 | $1.3M | Sell |
18,995
-4,910
| -21% | -$335K | 0.01% | 1047 |
|
|
2024
Q4 | $1.86M | Buy |
23,905
+13,159
| +122% | +$1.02M | 0.01% | 858 |
|
|
2024
Q3 | $720K | Buy |
10,746
+1,726
| +19% | +$116K | ﹤0.01% | 1263 |
|
|
2024
Q2 | $1.02M | Buy |
9,020
+1,393
| +18% | +$158K | 0.01% | 1052 |
|
|
2024
Q1 | $1.06M | Buy |
7,627
+522
| +7% | +$72.4K | 0.01% | 975 |
|
|
2023
Q4 | $896K | Sell |
7,105
-52
| -0.7% | -$6.56K | 0.01% | 987 |
|
|
2023
Q3 | $668K | Buy |
7,157
+2,927
| +69% | +$273K | 0.01% | 1048 |
|
|
2023
Q2 | $544K | Buy |
4,230
+393
| +10% | +$50.5K | 0.01% | 1145 |
|
|
2023
Q1 | $446K | Sell |
3,837
-2,388
| -38% | -$277K | 0.01% | 1155 |
|
|
2022
Q4 | $696K | Buy |
+6,225
| New | +$696K | 0.02% | 646 |
|
|
2022
Q1 | – | Sell |
-6,748
| Closed | -$906K | – | 1279 |
|
|
2021
Q4 | $906K | Buy |
+6,748
| New | +$906K | 0.01% | 780 |
|
|
2020
Q4 | – | Sell |
-5,864
| Closed | -$604K | – | 1011 |
|
|
2020
Q3 | $604K | Sell |
5,864
-6,612
| -53% | -$681K | 0.02% | 514 |
|
|
2020
Q2 | $1.26M | Buy |
12,476
+6,412
| +106% | +$650K | 0.05% | 306 |
|
|
2020
Q1 | $408K | Sell |
6,064
-244
| -4% | -$16.4K | 0.02% | 511 |
|
|
2019
Q4 | $344K | Sell |
6,308
-908
| -13% | -$49.5K | 0.01% | 625 |
|
|
2019
Q3 | $283K | Buy |
+7,216
| New | +$283K | 0.01% | 651 |
|